Banque Cantonale Vaudoise Has $31,000 Stake in The Cooper Companies, Inc. $COO

Banque Cantonale Vaudoise reduced its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 96.1% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 434 shares of the medical device company’s stock after selling 10,750 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Cooper Companies were worth $31,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Root Financial Partners LLC boosted its stake in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares in the last quarter. Bell Investment Advisors Inc raised its stake in shares of Cooper Companies by 106.3% in the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock valued at $29,000 after acquiring an additional 219 shares in the last quarter. CYBER HORNET ETFs LLC bought a new position in shares of Cooper Companies in the 2nd quarter valued at approximately $36,000. True Wealth Design LLC raised its stake in shares of Cooper Companies by 484.8% in the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock valued at $38,000 after acquiring an additional 383 shares in the last quarter. Finally, Cromwell Holdings LLC lifted its holdings in Cooper Companies by 128.8% in the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after purchasing an additional 273 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on COO shares. Rothschild & Co Redburn cut Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price for the company. in a research report on Wednesday, March 4th. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Sunday, June 21st. Citigroup restated a “neutral” rating and issued a $69.00 price objective (down from $80.00) on shares of Cooper Companies in a research note on Thursday, May 28th. Mizuho set a $85.00 price objective on shares of Cooper Companies and gave the stock an “outperform” rating in a report on Thursday, June 4th. Finally, The Goldman Sachs Group set a $61.00 target price on shares of Cooper Companies in a research note on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, Cooper Companies presently has an average rating of “Hold” and a consensus price target of $81.31.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $71.71 on Wednesday. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83. The firm has a market capitalization of $13.99 billion, a PE ratio of 60.77, a PEG ratio of 1.87 and a beta of 0.87. The business’s 50 day moving average is $64.18 and its 200-day moving average is $73.50. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.Cooper Companies’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Sell-side analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.